VAERS reports by lot

Merck HPV lot 1063U: VAERS reports

68 VAERS reports list lot 1063U as a Merck HPV vaccine, received between 2007-09-24 and 2022-03-11. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
68
Reports
51%
Marked serious
0
With a death outcome
26
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)5923%
Neurological4718%
Injection-site / Local reaction2811%
Gastrointestinal2610%
Cardiac / Cardiovascular249%
Musculoskeletal177%
Dermatological (non-injection-site)166%
Allergic / Anaphylactic104%
Respiratory104%
Autoimmune / Immune-mediated62%
Psychiatric / Neuropsychiatric62%
Thrombotic / Hematological42%
Reproductive / Menstrual42%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York8
Massachusetts4
California4
Pennsylvania4
Indiana3
Florida2
Iowa2
Michigan2
Colorado2
Minnesota2
Virginia2
Ohio2

Reports by month received

2007-092
2007-105
2007-1112
2007-128
2008-013
2008-023
2008-032
2008-043
2008-055
2008-061
2008-095
2008-103
2008-111
2009-011
2009-021
2009-031
2009-041
2009-053
2009-061
2009-071
2009-091
2010-051
2010-101
2010-121
2011-121
2022-031

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.